Imunon (IMNN) Invested Capital (2011 - 2026)
Imunon's (IMNN) quarterly Invested Capital came in at $893954.0 in Q1 2026, down 6.1% YoY from $952003.0 in Q1 2025, and down 10.71% on a QoQ basis from $1.0 million in Q4 2025.
Imunon (IMNN) Invested Capital (2011 - 2026) Analysis & Trends
Imunon (IMNN) has 16 years of Invested Capital data on file, last reported at $893954.0 in Q1 2026.
- Quarterly Invested Capital fell 6.1% year-over-year to $893954.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 34.44% YoY) and the FY2025 annual result came in at $1.0 million, down 4.47% from the prior year.
- Invested Capital eased to $893954.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $2.3 million in Q1 2023 to a low of $525078.0 in Q1 2024.
- A 5-year average of $1.4 million and a median of $1.2 million in 2022 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital surged 92.98% — and 2024, when it slumped 77.19%.
- Tracing IMNN's Invested Capital over 5 years: stood at $2.2 million in 2022, then plunged by 34.33% to $1.4 million in 2023, then declined by 27.35% to $1.0 million in 2024, then slipped by 4.47% to $1.0 million in 2025, then dropped by 10.71% to $893954.0 in 2026.
- The last three Invested Capital figures came in at $893954.0 (Q1 2026), $1.0 million (Q4 2025), and $910501.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 893,954.00 |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 910,501.00 |
| Jun 30, 2025 | 843,003.00 |
| Mar 31, 2025 | 952,003.00 |
| Dec 31, 2024 | 1.05 Mn |
| Jun 30, 2024 | 714,000.00 |
| Mar 31, 2024 | 525,078.00 |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 2.09 Mn |
| Jun 30, 2022 | 2.29 Mn |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.19 Mn |
| Mar 31, 2021 | 855,517.00 |